4519 — Chugai Pharmaceutical Share News
0.000.00%
Last trade - 00:00Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)
Japan's Nikkei hits record high on earnings, Middle East optimism
Table: Chugai Pharm -Q1 group results (IFRS)
Brief: Sarepta Therapeutics Announces Commercial Launch Of Elevidys In Japan
Table: Chugai Pharm -2025 group results (IFRS)
Japan's Nikkei rises as SoftBank Group trims losses; Topix hits new high
Brief: Renalys Pharma To Be Acquired By Chugai Pharmaceutical
Notice Concerning Making Renalys Pharma, Inc. A Wholly-Owned Subsidiary
Table: Chugai Pharm -9-MTH group results (IFRS)
Enter Into A License Agreement For The Development And Commercialization Of An Oral Formulation
Rani Therapeutics more than doubles on over $1 billion licensing deal with Japan's Chugai
Rani Therapeutics more than doubles on over $1 billion licensing deal with Japan's Chugai
Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma (updated)
Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma
Japan's Topix posts record-high close despite US tariffs on pharma
Nikkei falls as traders lock in gains after US trade deal rally (updated)